Healthy Male Clinical Trial
Official title:
A Single-centre, Randomised, Double-blind, Placebo Controlled Phase I Study in Two Parts: Part A to Assess a Safe and Tolerable Supratherapeutic Dose of TC-5214 After Single Ascending Oral Doses in Healthy Male Subjects, Followed by Part B: A Four-period Double-dummy Crossover Study to Investigate the Effect of 2 Single Doses (Therapeutic and Supratherapeutic) of TC-5214 on the QT/QTc Interval, Compared to Placebo, Using Moxifloxacin (Avelox®) as a Positive Control, in Healthy Male Subjects
This is a two part study. Part A will determine the maximum tolerated dose of TC-5214 administered to healthy male subjects in single ascending oral doses. This part of the study will define the highest dose of TC-5214 to be administered in Part B. Part B of this study will investigate the effect of TC-5214 on the electrical activity of the heart following single oral administration. The study will be carried out healthy male subjects in a four period crossover study with TC-5214 compared to placebo and oral moxifloxacin as a positive control. The safety, tolerability and pharmacokinetics of TC-5214 will also be evaluated.
n/a
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04135898 -
A Study Comparing SIBP-04 and Bevacizumab in Healthy Male Subjects
|
Phase 1 | |
| Completed |
NCT02395926 -
To Evaluate Safety and the Pharmacokinetic Characteristics After Oral Administration of HT-003 Compared With Choline Alfoscerate Capsule in Healthy Adult Male Volunteers
|
Phase 1 | |
| Recruiting |
NCT05849311 -
Phase I Trial of Envafolimab for Healthy Male Subjects
|
Phase 1 | |
| Active, not recruiting |
NCT06105255 -
A Study to Evaluate the Effects of D-1553 on PK of Midazolam, Caffeine, Rosuvastatin, Furosemide, Digoxin, and Itraconazole or Omeprazole on PK of D-1553
|
Phase 1 | |
| Completed |
NCT01651234 -
A Study to Assess Safety, Tolerability, and Pharmacokinetics of Orally Administered GCC4401C in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT02395913 -
Compare Safety and Pharmacokinetic Properties of Surfolase Capsule(Acebrophylline 100mg) and Surfolase CR(200mg)
|
Phase 1 | |
| Completed |
NCT06194500 -
A Study of Carbon-14-Labeled [14C]-LY3549492 in Healthy Participants
|
Phase 1 | |
| Completed |
NCT05202912 -
Food Effect Study of IDX-1197 in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT04828265 -
Study of Aldafermin (NGM282) in Healthy Adult Male Japanese and Non-Japanese Subjects
|
Phase 1 |